Previous studies involving AD organoids utilizing serum samples from AD patients and iPSCs from patients with familial PSEN mutations and sporadic APOE mutations have all observed increased levels of Aβ (Chen et al., 2021; Vanova et al., 2023; Zhao et al., 2020). This evidence concerns the gene APOE and Alzheimer disease.